Trial intelligence / Profile preview

ALC for Fatigue in Breast Cancer Patients Undergoing Radiation

NCT00555841Phase 2Terminated

Sponsor
Leadiant Biosciences
Start
Mar 2007
Primary completion
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetyl-l-carnitine in fatigue, sponsored by Leadiant Biosciences. Started Mar 2007; status: terminated.

02

Drugs

acetyl-l-carnitine
03

Conditions

fatigue

Beyond the preview

Go deeper on NCT00555841.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00555841.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call